TherapeuticsMD (TXMD) Competitors $1.06 +0.02 (+1.92%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$1.03 -0.03 (-2.36%) As of 09:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TXMD vs. IVVD, ACHL, ICCC, XLO, ALVR, CELU, KZR, VYNE, ALRN, and NBRVShould you be buying TherapeuticsMD stock or one of its competitors? The main competitors of TherapeuticsMD include Invivyd (IVVD), Achilles Therapeutics (ACHL), ImmuCell (ICCC), Xilio Therapeutics (XLO), AlloVir (ALVR), Celularity (CELU), Kezar Life Sciences (KZR), VYNE Therapeutics (VYNE), Aileron Therapeutics (ALRN), and Nabriva Therapeutics (NBRV). These companies are all part of the "pharmaceutical products" industry. TherapeuticsMD vs. Invivyd Achilles Therapeutics ImmuCell Xilio Therapeutics AlloVir Celularity Kezar Life Sciences VYNE Therapeutics Aileron Therapeutics Nabriva Therapeutics TherapeuticsMD (NASDAQ:TXMD) and Invivyd (NASDAQ:IVVD) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, community ranking, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Do analysts recommend TXMD or IVVD? Invivyd has a consensus target price of $7.89, indicating a potential upside of 1,840.82%. Given Invivyd's stronger consensus rating and higher possible upside, analysts plainly believe Invivyd is more favorable than TherapeuticsMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TherapeuticsMD 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Invivyd 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is TXMD or IVVD more profitable? Invivyd has a net margin of 0.00% compared to TherapeuticsMD's net margin of -207.77%. TherapeuticsMD's return on equity of -14.08% beat Invivyd's return on equity.Company Net Margins Return on Equity Return on Assets TherapeuticsMD-207.77% -14.08% -9.61% Invivyd N/A -155.33%-114.88% Does the media favor TXMD or IVVD? In the previous week, TherapeuticsMD and TherapeuticsMD both had 1 articles in the media. TherapeuticsMD's average media sentiment score of 0.50 beat Invivyd's score of -1.00 indicating that TherapeuticsMD is being referred to more favorably in the media. Company Overall Sentiment TherapeuticsMD Positive Invivyd Negative Which has better earnings & valuation, TXMD or IVVD? TherapeuticsMD has higher revenue and earnings than Invivyd. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTherapeuticsMD$1.30M9.40-$10.28MN/AN/AInvivydN/AN/A-$198.64M-$1.96-0.21 Do insiders and institutionals hold more shares of TXMD or IVVD? 30.7% of TherapeuticsMD shares are held by institutional investors. Comparatively, 70.4% of Invivyd shares are held by institutional investors. 2.3% of TherapeuticsMD shares are held by insiders. Comparatively, 17.9% of Invivyd shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, TXMD or IVVD? TherapeuticsMD has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Invivyd has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Does the MarketBeat Community favor TXMD or IVVD? TherapeuticsMD received 370 more outperform votes than Invivyd when rated by MarketBeat users. However, 80.00% of users gave Invivyd an outperform vote while only 58.57% of users gave TherapeuticsMD an outperform vote. CompanyUnderperformOutperformTherapeuticsMDOutperform Votes38658.57% Underperform Votes27341.43% InvivydOutperform Votes1680.00% Underperform Votes420.00% SummaryInvivyd beats TherapeuticsMD on 8 of the 15 factors compared between the two stocks. Get TherapeuticsMD News Delivered to You Automatically Sign up to receive the latest news and ratings for TXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TXMD vs. The Competition Export to ExcelMetricTherapeuticsMDPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.22M$6.52B$5.34B$9.11BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A4.4457.4913.22Price / Sales9.40310.281,275.6876.05Price / CashN/A22.6336.6032.90Price / Book0.384.964.874.58Net Income-$10.28M$154.90M$118.05M$224.84M7 Day Performance6.31%1.38%1.50%2.37%1 Month Performance-4.50%0.44%2.55%4.40%1 Year Performance-52.49%3.11%25.83%20.11% TherapeuticsMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TXMDTherapeuticsMD1.0851 of 5 stars$1.06+1.9%N/A-52.5%$12.22M$1.30M0.00420IVVDInvivyd2.9866 of 5 stars$0.40-11.7%$7.89+1,877.3%-91.4%$47.72M$11.56M-0.20100Short Interest ↑Negative NewsACHLAchilles Therapeutics2.6955 of 5 stars$1.16-2.1%$4.00+244.8%+38.6%$47.68MN/A-0.70250Positive NewsICCCImmuCell0.1068 of 5 stars$5.33+2.7%N/A+3.7%$47.50M$23.84M-10.6670XLOXilio Therapeutics3.2147 of 5 stars$1.07-2.7%$4.00+273.8%+67.9%$47.04M$4.62M-0.6270Positive NewsALVRAlloVir1.5653 of 5 stars$0.40-8.2%N/A-40.7%$46.61MN/A-0.46110Stock SplitHigh Trading VolumeCELUCelularity0.3714 of 5 stars$2.10-2.8%N/A-21.8%$46.17M$48.20M0.00220Short Interest ↑Positive NewsKZRKezar Life Sciences3.9143 of 5 stars$6.31-3.1%$39.50+526.0%-25.4%$46.04M$7M-0.4860VYNEVYNE Therapeutics3.8125 of 5 stars$3.11-9.3%$6.88+121.1%+51.7%$45.88M$493,000.00-3.6230Gap UpALRNAileron Therapeutics3.1009 of 5 stars$2.11+9.3%$19.00+800.5%N/A$45.72MN/A-0.689NBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M-0.0770 Related Companies and Tools Related Companies Invivyd Alternatives Achilles Therapeutics Alternatives ImmuCell Alternatives Xilio Therapeutics Alternatives AlloVir Alternatives Celularity Alternatives Kezar Life Sciences Alternatives VYNE Therapeutics Alternatives Aileron Therapeutics Alternatives Nabriva Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TXMD) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
